Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-concentration Atropine for Myopia Control
NCT05597163Unknown
- Start
- Jan 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of Myopine in myopia (4 arms). Primary endpoint: Proportion of Spherical Equivalent changes over -0.75D at 2 years. Status: unknown.
02
Drugs
Myopine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05597163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05597163.